Tregs constrain CD8+ T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy https://www.biorxiv.org/content/10.1101/2023.01.30.526116v1?med=mas
Tregs constrain CD8+ T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy https://www.biorxiv.org/content/10.1101/2023.01.30.526116v1?med=mas